Lin et al. found that patients with IBD had higher stool IgA and IgG concentrations and a higher percentage of IgA- and IgG-coated bacteria in faeces compared with healthy controls, which may be part of a dysregulated mucosal immune response to commensal microbiota in IBD [36]. This evidence concerns the gene CD79A and inflammatory bowel disease.